Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 15
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07451769 Selective Activation of the Adrenomedullin Receptors in Migraine |
Adrenomedullin | Migraine | Non applicable | RECRUITING | En attente / non publié | Danish Headache Center | Denmark · Danish Headache Center, Glostrup Municipali… | 2026-03-12 → 2032-12-20 | Ouvrir |
| NCT05281770 Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real … |
Erenumab | Migraine | À vérifier | UNKNOWN | En attente / non publié | Amgen | Austria · Clinic Hietzing, Vienna, Austria | Medical … | 2022-10-01 → 2025-12-01 | Ouvrir |
| NCT03927144 Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients |
AMG334 | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | United States, Argentina, Austria, Belgium, Czechia, … | 2019-05-15 → 2022-09-30 | Ouvrir |
| NCT04265755 INTERROGATE — Biomarker and Genetic Predictors of Erenumab Treatment Re… |
Erenumab | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | Denmark, Iceland · Glostrup Hospital, Glostrup Munici… | 2020-10-26 → 2023-01-18 | Ouvrir |
| NCT03832998 OASIS(CM) — Efficacy and Safety of Erenumab in Pediatric Subjects With … |
Erenumab Dose 1 | Migraine | Phase 3 | COMPLETED | En attente / non publié | Amgen | United States, Belgium, Canada, Colombia, Finland, Ge… | 2019-09-05 → 2026-01-07 | Ouvrir |
| NCT05889455 COMPETE — Effect of Sildenafil in Individuals With Migraine Pretreated … |
Sildenafil | Migraine | Non applicable | COMPLETED | En attente / non publié | Herlev Hospital | Denmark · Danish Headache Center, Copenhagen, Denmark | 2023-04-20 → 2023-10-12 | Ouvrir |
| NCT05889442 COLLIDE — Effect of Levcromakalim in Individuals With Migraine Pretreat… |
Levcromakalim | Migraine | Non applicable | COMPLETED | En attente / non publié | Danish Headache Center | Denmark · Danish Headache Center, Copenhagen, Denmark | 2023-03-09 → 2023-06-12 | Ouvrir |
| NCT04825678 A Study to Evaluate Treatment Satisfaction With Erenumab in Participant… |
Erenumab | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | United States · ActivMed Practices and Research, LLC,… | 2021-06-11 → 2023-09-28 | Ouvrir |
| NCT04084314 APOLLON — Assessment of Prolonged Safety and tOLerability of in Migrain… |
Erenumab | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | Germany · Novartis Investigative Site, Aachen, German… | 2019-09-30 → 2023-03-13 | Ouvrir |
| NCT04628429 CGRP-1 — CGRP Inhibition, Autonomic Function, and Migraine |
Erenumab | Migraine | À vérifier | RECRUITING | En attente / non publié | Amgen | Austria · Medical University of Vienna, Vienna, Austr… | 2020-10-01 → 2026-12 | Ouvrir |
| NCT04152434 Treatment of Chronic Migraine With Erenumab Alone or as an Add on Thera… |
Erenumab Auto-Injector | Migraine | À vérifier | COMPLETED | En attente / non publié | Clinique des Céphalées de Montréal | Canada · Guy Pierre Boudreau, Montreal, Canada | 2019-04-01 → 2019-08-30 | Ouvrir |
| NCT04252742 EMBRACE — Erenumab - Comprehensive Assessment of Efficacy in (High-Freq… |
Erenumab | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | United States, Bulgaria, Czechia, Hungary, Italy, Pol… | 2020-09-15 → 2023-10-26 | Ouvrir |
| NCT03836040 OASIS(EM) — Efficacy and Safety of Erenumab in Pediatric Participants W… |
Erenumab Dose 1 | Migraine | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Amgen | United States, Belgium, Canada, Colombia, Finland, Ge… | 2019-07-19 → 2026-11-19 | Ouvrir |
| NCT07103694 i-NEED: NEw migrainE Drugs Database |
anti-CGRP monoclonal antibodies | Migraine | À vérifier | RECRUITING | En attente / non publié | IRCCS San Raffaele Roma | Italy · IRCCS San Raffaele, Rome, Italy | Istituto Au… | 2022-03-24 → 2026-12-31 | Ouvrir |
| NCT07159750 EUREkA — Real-world Prospective Study on the Use of Anti-CGRP Drugs in … |
CGRP antibody or gepant | Migraine | À vérifier | RECRUITING | En attente / non publié | Hospital Universitari Vall d'Hebr… | United States, Argentina, Chile, Colombia, Croatia, G… | 2024-01-02 → 2026-01 | Ouvrir |